These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. All patients with heart failure and intraventricular conduction defect or dyssynchrony should not receive cardiac resynchronization therapy. Greenberg B; Mehra MR Circulation; 2006 Dec; 114(24):2685-90; discussion 2691. PubMed ID: 17159074 [No Abstract] [Full Text] [Related]
4. Cardiac resynchronization therapy is important for all patients with congestive heart failure and ventricular dyssynchrony. Abraham WT Circulation; 2006 Dec; 114(24):2692-8; discussion 2698. PubMed ID: 17159075 [No Abstract] [Full Text] [Related]
5. Update on the pathophysiological basics of cardiac resynchronization therapy. Auricchio A; Prinzen FW Europace; 2008 Jul; 10(7):797-800. PubMed ID: 18482999 [TBL] [Abstract][Full Text] [Related]
11. An epidemic of dyssynchrony: but what does it mean? Kass DA J Am Coll Cardiol; 2008 Jan; 51(1):12-7. PubMed ID: 18174030 [TBL] [Abstract][Full Text] [Related]
12. Cardiac resynchronization therapy--who benefits? Separating myths from facts. Deshpande S; Tol S; Lokhandwala Y Indian Heart J; 2007; 59(1 Suppl A):A57-62. PubMed ID: 19104133 [No Abstract] [Full Text] [Related]
13. Reappraisal of ECG lead V1 in the assessment of cardiac resynchronization. Barold SS Pacing Clin Electrophysiol; 2015 Mar; 38(3):291-4. PubMed ID: 25652446 [No Abstract] [Full Text] [Related]
14. [Electrocardiographic problems in patients with pacemakers. I. General remarks on cardiac electrostimulation and electrocardiographic findings]. Giordano MP; Roncarolo PL; Aldrovandi A Minerva Cardioangiol; 1980 Dec; 28(12):781-6. PubMed ID: 7219731 [No Abstract] [Full Text] [Related]